Nigeria, Brazil emerging as key pharma export markets for India: Commerce ministry
The commerce ministry in its data has showed that amid global economic uncertainty, Brazil and Nigeria are emerging as major export destinations for Indian pharmaceutical firms. Nigeria has become one of the fastest-growing export destinations, adding $179 million in exports and contributing over 14 per cent to the total export growth during the first eight months of this fiscal year.
Moreover, the data showed during April-November FY26, Brazil also recorded an increase of nearly $100 million exports. These markets show increasing healthcare access, expanding public procurement, and growing reliance on Indian generics, reinforcing India's role as a preferred supplier to high growth demand intensive regions. The country's pharmaceutical exports rose by 6.5 per cent to $20.48 billion during April-November 2025-26.
Further, the data showed that the US continues to be the single largest destination, accounting for over 31 per cent of exports in April-November 2025, while the overall growth profile highlights a broadening of demand across multiple geographies, strengthening the stability of India's pharma export basket. Alongside the US, countries such as France, the Netherlands, Canada, Germany, and South Africa recorded steady growth, collectively supporting export expansion while maintaining stable shares.
